Anupam Rasayan signs LOI worth $95 million with Multinational Crop Protection Company. Anupam Rasayan (NSE, BSE: ANURAS), one of India’s leading custom synthesis & speciality […]
Pharma
Zydus, a leading discovery based, global pharmaceutical company today announced that it has received permission from the USFDA to initiate the Phase 2(b)/3 Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled adaptive clinical trial to evaluate Efficacy and Safety of […]
Dragged by a fall in its US sales, Torrent Pharma Ltd. saw its profit after tax (PAT) for the second quarter ended September 30, 2021 rise marginally […]
Gland Pharma’s Q2FY22 Revenue grew by 30% with Net Profit growth of 38%. Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable focused pharmaceutical company, today announced its financial results for the second quarter and […]
Indian Pharmaceutical Alliance (IPA) Announces New Office Bearers. Indian Pharmaceutical Alliance announced on Monday, October 04, 2021 the appointment of Mr Samir Mehta, Chairman of […]
Anupam Rasayan (NSE, BSE: ANURAS), one of India’s leading custom synthesis & speciality chemical player, has signed Letter of Intent (LOI) worth Rs 145 crore […]
World’s first Plasmid DNA Vaccine for COVID-19, ZyCoV-D will be administered in three doses. Apart from adults, for the first time adolescents in the age […]
Ahmedabad, For the first quarter ended June 30, 2021, Zydus Cadila reported net profit of Rs. 587 crores, up by 29% on a y-o-y basis. […]
The management said Sun Pharma witnessed a strong Q1, driven by a combination of robust core business growth, low base and some sale of Covid […]
Torrent Pharma announces Q1 FY22 results. India: Indiarevenues at Rs 1,093 crores grew by 18%. As per AIOCD data, Torrent’s Q1 FY22 growth was 24% […]
